Tag: $BioNTech

BioNTech(BNTX) stock was rising after the drugmaker reported better-than-expected results early Monday. The company’s second-quarter loss came in at 1.60 euros per share on revenue of €261 million, beating analysts’ expectations of a loss per share of €2.28 on revenue of €151 million, according to FactSet.

Bristol Myers Squibb has signed a partnership worth up to $11bn to develop a BioNTech cancer drug that has the potential to beat the world’s bestselling medicine Keytruda.

Shares of BioNTech, the German company that developed a Covid-19 vaccine with Pfizer , were falling in early trading Monday after second-quarter revenue missed expectations.the U.S. dollar strengthened versus major rivals.